Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |